Asthma is considered to be one of the world's most common diseases affecting the population, and is also a life-threatening condition affecting patients'.
Inhalation Sciences Sweden : news roundup spring 2021
03/03/2021 | 05:04am EDT
Send by mail :
Message :
AQUILON PHARMA PURCHASES PRECISEINHALE FOR INNOVATIVE ASTHMA AND COPD RESEARCH Aquilon Pharma, based in Belgium, has purchased ISAB s high-precision R&D system PreciseInhale®, plus its Nose-Only and Intratracheal Exposure Modules, to help drive forward their innovative portfolio of new formulations to improve the efficacy of inhaled drugs for asthma and COPD (Chronic Pulmonary Obstructive disorder).
IT FOR ADVANCED AUTOMATION, USABILITY AND FLEXIBILITY Graz University s Snezana Radivojev completed a month s onsite contract research at ISAB s labs in Stockholm working with the advanced
in vitro solution tool Dissolv
It®.Radivojev has spent four years researching a wide range of simulated lung models - so how did Dissolv